Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population.

ABSTRACT:

Background

It is unclear whether patients with inflammatory bowel disease (IBD) are at increased risk of COVID-19.

Objectives

This observational study compared the prevalence of COVID-19 symptoms, diagnosis and hospitalization in IBD patients with a control population with non-inflammatory bowel disorders.

Methods

This multicentre study, included 2733 outpatients (1397 IBD patients and 1336 controls), from eight major gastrointestinal centres in Lombardy, Italy. Patients were invited to complete a web-based questionnaire regarding demographic, historical and clinical features over the previous 6 weeks. The prevalence of COVID-19 symptoms, diagnosis and hospitalization for COVID-19 was assessed.

Results

1810 patients (64%) responded to the questionnaire (941 IBD

SUBMITTER: Maconi G 

PROVIDER: S-EPMC7762705 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature